From the Molecular Cardiology Unit and the Experimental Research
Laboratory of the Division of Cardiology (Q.L., R.B., Y.Q., X-L.T., B.A.F.),
the Department of Anatomic Pathology (S.S.M.), and the Center for Genetics and
Molecular Medicine (B.A.F.), University of Louisville, Louisville, Ky.
Correspondence to Brent A. French, PhD, Department of Biomedical Engineering, University of Virginia Health Sciences Center, Stacey Hall, 1105 W Main St, Charlottesville, VA 22903.
Background—Administration of Cu/Zn
superoxide dismutase (SOD) without catalase fails to alleviate
myocardial stunning, but extracellular SOD (Ec-SOD) may be more
effective because it binds to heparan sulfate proteoglycans on the
cellular glycocalyx. We therefore used in vivo gene transfer to
increase systemic levels of Ec-SOD and determined whether this gene
therapy protects against myocardial stunning.
Methods and Results—The cDNA for human Ec-SOD was cloned behind
the cytomegalovirus (CMV) promoter and incorporated into a
replication-deficient adenovirus (Ad5/CMV/Ec-SOD). Injection of this
virus (2x108 pfu/kg IV) produced high levels of Ec-SOD in
the liver, which could be redistributed to the heart and other organs
by injection of heparin. Conscious rabbits underwent a sequence of six
4-minute coronary occlusion/4-minute reperfusion cycles for 3
consecutive days starting 3 days after intravenous
injection of Ad5/CMV/Ec-SOD or Ad5/CMV/nls/LacZ (negative control).
Both groups were given heparin (2000 U/kg IV) 2 hours before the first
sequence of occlusions. The severity of myocardial stunning was
measured as the total deficit of LV wall thickening after the last
reperfusion. On day 1, the total deficit of wall thickening was
markedly decreased in Ad5/CMV/Ec-SOD rabbits versus controls and
similar to that seen on days 2 and 3 in controls.
Conclusions—The results demonstrate that in vivo gene transfer of
the cDNA encoding Ec-SOD provides the heart with substantial protection
against myocardial stunning without the need for concomitant
administration of catalase. The present observations provide the
basis for controlling gene therapy at the posttranslational level and
for simultaneously protecting multiple organs from oxidant
stress.
© 1998 American Heart Association, Inc.
Basic Science Reports
Gene Therapy With Extracellular Superoxide Dismutase Attenuates Myocardial Stunning in Conscious Rabbits
Key Words: genes • superoxide dismutase • free radicals • stunning, myocardial • ischemia • reperfusion
This article has been cited by other articles:
 |
|
 |
|
  R. M. Mentzer Jr, M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2008; 3(2008): 443 - 464. [Full Text]
|
|
|
|
 |
|
 Z. Lu, X. Xu, X. Hu, G. Zhu, P. Zhang, E. D. van Deel, J. P. French, J. T. Fassett, T. D. Oury, R. J. Bache, et al. Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload Induced Left Ventricular Hypertrophy and Dysfunction Hypertension, January 1, 2008; 51(1): 19 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Nordlie, L. E. Wold, B. Z. Simkhovich, C. Sesti, and R. A. Kloner Molecular Aspects of Ischemic Heart Disease: Ischemia/Reperfusion-Induced Genetic Changes and Potential Applications of Gene and RNA Interference Therapy Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 17 - 30. [Abstract] [PDF]
|
|
|
|
|
|
Y. L. Tang, K. Qian, Y. C. Zhang, L. Shen, and M. I. Phillips A Vigilant, Hypoxia-Regulated Heme Oxygenase-1 Gene Vector in the Heart Limits Cardiac Injury After Ischemia-Reperfusion In Vivo Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 251 - 263. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Iida, Y. Chu, J. Francis, R. M. Weiss, C. A. Gunnett, F. M. Faraci, and D. D. Heistad Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H525 - H532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Park, W.-N. Qi, Y. Cai, I. Zelko, J. Q. Liu, L.-E. Chen, J. R. Urbaniak, and R. J. Folz Skeletal muscle reperfusion injury is enhanced in extracellular superoxide dismutase knockout mouse Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H181 - H187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Abunasra, R. T. Smolenski, J. Yap, M. Sheppard, T. O'Brien, and M. H. Yacoub Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 998 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Mentzer Jr., M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2003; 2(2003): 413 - 438. [Full Text]
|
|
|
|
 |
|
 M. O. Laukkanen, A. Kivela, T. Rissanen, J. Rutanen, M. K. Karkkainen, O. Leppanen, J. H. Brasen, and S. Yla-Herttuala Adenovirus-Mediated Extracellular Superoxide Dismutase Gene Therapy Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta Circulation, October 8, 2002; 106(15): 1999 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fukai, R. J Folz, U. Landmesser, and D. G Harrison Extracellular superoxide dismutase and cardiovascular disease Cardiovasc Res, August 1, 2002; 55(2): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bonatti, C. Haeusler, A. Klaus, M. Fink, A. Hammerer-Lercher, and G. Laufer Acceptance of gene therapy by the heart surgery patient Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Phillips, Y. Tang, K. Schmidt-Ott, K. Qian, and S. Kagiyama Vigilant Vector: Heart-Specific Promoter in an Adeno-Associated Virus Vector for Cardioprotection Hypertension, February 1, 2002; 39(2): 651 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Abunasra, R. T. Smolenski, K. Morrison, J. Yap, M. N. Sheppard, T. O'Brien, K. Suzuki, J. Jayakumar, and M. H. Yacoub Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, R. Bolli, Y. Qiu, X.-L. Tang, Y. Guo, and B. A. French Gene Therapy With Extracellular Superoxide Dismutase Protects Conscious Rabbits Against Myocardial Infarction Circulation, April 10, 2001; 103(14): 1893 - 1898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakane, Y. Chu, F. M. Faraci, L. W. Oberley, D. D. Heistad, and P. H. Chan Gene Transfer of Extracellular Superoxide Dismutase Increases Superoxide Dismutase Activity in Cerebrospinal Fluid Editorial Comment Stroke, January 1, 2001; 32(1): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dieterich, U. Bieligk, K. Beulich, G. Hasenfuss, and J. Prestle Gene Expression of Antioxidative Enzymes in the Human Heart : Increased Expression of Catalase in the End-Stage Failing Heart Circulation, January 4, 2000; 101(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: an update Cardiovasc Res, December 1, 1999; 44(3): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Asimakis, S. Lick, and C. Patterson Postischemic Recovery of Contractile Function is Impaired in SOD2+/- but Not SOD1+/- Mouse Hearts Circulation, February 26, 2002; 105(8): 981 - 986. [Abstract] [Full Text] [PDF]
|
|